Broadfin Capital as of June 30, 2014
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 69 positions in its portfolio as reported in the June 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Infinity Pharmaceuticals (INFIQ) | 29.7 | $425M | 1.4M | 295.33 | |
| Flamel Technologies | 5.5 | $79M | 5.3M | 15.00 | |
| D Horizon Pharma | 4.8 | $69M | 4.4M | 15.82 | |
| AngioDynamics (ANGO) | 3.4 | $49M | 3.0M | 16.33 | |
| Emergent BioSolutions (EBS) | 3.3 | $47M | 2.1M | 22.46 | |
| AMAG Pharmaceuticals | 2.8 | $41M | 2.0M | 20.72 | |
| BioDelivery Sciences International | 2.8 | $41M | 3.4M | 12.07 | |
| Heron Therapeutics (HRTX) | 2.4 | $35M | 2.8M | 12.32 | |
| DepoMed | 2.4 | $34M | 2.5M | 13.90 | |
| Progenics Pharmaceuticals | 2.0 | $29M | 6.6M | 4.31 | |
| Tetraphase Pharmaceuticals | 2.0 | $29M | 2.1M | 13.49 | |
| Aegerion Pharmaceuticals | 1.8 | $26M | 810k | 32.09 | |
| Anacor Pharmaceuticals In | 1.8 | $26M | 1.4M | 17.73 | |
| Pernix Therapeutics Holdings | 1.8 | $25M | 3.5M | 7.18 | |
| Retrophin | 1.7 | $25M | 1.7M | 14.85 | |
| Derma Sciences | 1.5 | $21M | 1.8M | 11.56 | |
| Universal American | 1.4 | $21M | 2.5M | 8.33 | |
| Rigel Pharmaceuticals (RIGL) | 1.4 | $20M | 5.6M | 3.63 | |
| Novadaq Technologies | 1.4 | $20M | 1.2M | 16.48 | |
| Natus Medical | 1.3 | $19M | 765k | 25.14 | |
| Impax Laboratories | 1.3 | $18M | 609k | 29.99 | |
| AtriCure (ATRC) | 1.3 | $18M | 985k | 18.38 | |
| Discovery Laboratories | 1.0 | $14M | 8.1M | 1.78 | |
| Aratana Therapeutics | 0.9 | $13M | 817k | 15.61 | |
| Dynavax Technologies Corporation | 0.9 | $12M | 7.7M | 1.60 | |
| Rite Aid Corporation | 0.8 | $12M | 1.6M | 7.17 | |
| Liberator Medical Hld | 0.8 | $12M | 3.1M | 3.75 | |
| Eleven Biotherapeutics | 0.8 | $11M | 858k | 13.18 | |
| IGI Laboratories | 0.8 | $11M | 2.1M | 5.31 | |
| Corium Intl | 0.8 | $11M | 1.4M | 7.77 | |
| Syneron Medical Ltd ord | 0.7 | $10M | 1.0M | 10.32 | |
| Zogenix | 0.7 | $10M | 5.1M | 2.01 | |
| Cempra | 0.7 | $10M | 955k | 10.73 | |
| Brookdale Senior Living (BKD) | 0.7 | $10M | 303k | 33.34 | |
| Idera Pharmaceuticals | 0.7 | $10M | 3.5M | 2.90 | |
| Cardica | 0.7 | $10M | 8.9M | 1.14 | |
| BioScrip | 0.7 | $9.6M | 1.1M | 8.34 | |
| Xencor (XNCR) | 0.6 | $9.0M | 775k | 11.62 | |
| Sagent Pharmaceuticals | 0.6 | $8.5M | 330k | 25.86 | |
| Qlt | 0.6 | $8.2M | 1.3M | 6.18 | |
| Antares Pharma | 0.6 | $8.1M | 3.1M | 2.67 | |
| DURECT Corporation | 0.6 | $8.0M | 4.4M | 1.82 | |
| Oxygenbiotherapeutics Inccom Par | 0.6 | $8.0M | 2.0M | 4.08 | |
| Tonix Pharmaceuticls | 0.5 | $6.7M | 468k | 14.35 | |
| Chemocentryx | 0.4 | $6.1M | 1.1M | 5.85 | |
| Auxilium Pharmaceuticals | 0.4 | $6.0M | 300k | 20.06 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.4 | $6.1M | 2.4M | 2.53 | |
| Ignyta | 0.4 | $5.8M | 225k | 25.92 | |
| CareFusion Corporation | 0.4 | $5.5M | 125k | 44.35 | |
| Pozen | 0.4 | $5.5M | 660k | 8.33 | |
| Recro Pharma (SCTL) | 0.4 | $5.4M | 672k | 8.01 | |
| Aquinox Pharmaceuticals | 0.3 | $4.8M | 511k | 9.43 | |
| Redhill Biopharma Ltd cmn | 0.3 | $4.6M | 263k | 17.49 | |
| Dipexium Pharmaceuticals | 0.3 | $4.6M | 475k | 9.70 | |
| Agenus (AGEN) | 0.3 | $3.8M | 1.2M | 3.22 | |
| Mirati Therapeutics | 0.3 | $3.7M | 185k | 20.00 | |
| La Jolla Pharmaceuticl Com Par | 0.2 | $3.6M | 388k | 9.18 | |
| Flexion Therapeutics | 0.2 | $3.5M | 263k | 13.48 | |
| Rxi Pharmaceuticals | 0.2 | $3.4M | 1.1M | 3.02 | |
| Trevena | 0.2 | $3.4M | 600k | 5.65 | |
| Biota Pharmaceuticals | 0.2 | $3.2M | 1.1M | 2.85 | |
| CAS Medical Systems | 0.2 | $2.9M | 1.4M | 2.01 | |
| Biodel | 0.2 | $2.9M | 1.3M | 2.16 | |
| Celsus Therapeutics Plc sponsored adr ne | 0.2 | $2.9M | 471k | 6.20 | |
| Anthera Pharmaceutcls | 0.2 | $2.6M | 766k | 3.39 | |
| Lipocine | 0.1 | $1.6M | 265k | 6.10 | |
| Digirad Corporation | 0.1 | $1.2M | 333k | 3.56 | |
| Teva Pharmaceutical Industries (TEVA) | 0.0 | $210k | 4.0k | 52.50 | |
| Haemonetics Corporation (HAE) | 0.0 | $127k | 3.6k | 35.28 |
